PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
CRH plc (CRH)
114.271.68 (1.49%)
111.48 - 114.40
76.75 - 114.39
5.09M / 4.21M (Avg.)
23.96 | 4.77
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-0.22%
Negative revenue growth while VMC stands at 24.98%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
-71.13%
Negative gross profit growth while VMC is at 58.77%. Joel Greenblatt would examine cost competitiveness or demand decline.
-92.68%
Negative EBIT growth while VMC is at 257.21%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-92.68%
Negative operating income growth while VMC is at 257.21%. Joel Greenblatt would press for urgent turnaround measures.
-0.27%
Negative net income growth while VMC stands at 910.23%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-0.96%
Share reduction while VMC is at 1.18%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
-1.17%
Reduced diluted shares while VMC is at 1.11%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
336.77%
10Y revenue/share CAGR above 1.5x VMC's 102.41%. David Dodd would confirm if management’s strategic vision consistently outperforms the competitor.
218.02%
5Y revenue/share CAGR above 1.5x VMC's 23.37%. David Dodd would look for consistent product or market expansions fueling outperformance.
97.74%
3Y revenue/share CAGR above 1.5x VMC's 21.51%. David Dodd would confirm if there's an emerging competitive moat driving recent gains.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
241.78%
Net income/share CAGR above 1.5x VMC's 85.58% over 10 years. David Dodd would confirm if brand, IP, or scale secure this persistent advantage.
490.92%
5Y net income/share CAGR above 1.5x VMC's 132.67%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.
99.03%
3Y net income/share CAGR above 1.5x VMC's 7.73%. David Dodd would confirm the company’s short-term strategies outmatch the competitor significantly.
No Data
No Data available this quarter, please select a different quarter.
143.10%
5Y equity/share CAGR 1.25-1.5x VMC's 114.63%. Bruce Berkowitz confirms if reinvested profits or buybacks explain the superior buildup.
79.17%
3Y equity/share CAGR similar to VMC's 74.07%. Walter Schloss sees both having parallel profitability or reinvestment over 3 years.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.